Researchers at the University of Houston College of Pharmacy have identified a promising approach to prevent or reduce muscle loss in patients with pancreatic cancer-induced cachexia, a debilitating condition that affects 60–85% of these patients. Cachexia causes severe muscle wasting, weakness, and reduced quality of life, making cancer treatments harder to tolerate and lowering survival rates.
What is Cancer Cachexia?
Cachexia is more than simple weight loss or poor nutrition. It results from drastic changes in metabolism triggered by cancer, leading to accelerated breakdown of muscle tissue and decreased muscle protein production. This makes everyday activities difficult and further complicates treatment.
Central to this process are cellular pathways—networks of molecules inside cells that respond to stress signals and maintain balance. When these pathways malfunction, they can accelerate disease progression, including muscle wasting.
A Key Molecular Pathway Identified
At the University of Houston, Ashok Kumar, Else and Philip Hargrove Endowed Professor of Drug Discovery and director of The Institute for Muscle Biology and Cachexia, discovered a specific pathway, known as IRE1α/XBP1, that plays a critical role in muscle deterioration.
“We show that the IRE1α/XBP1 pathway is a key contributor to muscle wasting,” Kumar said. “Removing the XBP1 transcription factor in skeletal muscle significantly reduces muscle loss caused by pancreatic tumors.”
This pathway operates in the endoplasmic reticulum, a vital cell structure that produces proteins and lipids. In pancreatic cancer, muscle wasting is driven by both increased protein breakdown and reduced protein production, causing overall loss of muscle mass.
Broader Implications for Muscle Biology
The IRE1α/XBP1 pathway affects multiple biological processes that together drive muscle wasting. Kumar notes that these findings may extend beyond pancreatic cancer: “Our results suggest this pathway could also play a role in muscle loss seen in other cancers. Future studies will explore its potential as a broader therapeutic target.”
Related topic：
